{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T12:33:06Z","timestamp":1723033986582},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDT"],"published-print":{"date-parts":[[2011,8,1]]},"DOI":"10.2174\/138945011796150343","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T12:07:48Z","timestamp":1308571668000},"page":"1364-1371","source":"Crossref","is-referenced-by-count":8,"title":["Understanding the Use of Immunosuppressive Agents in the Clinical Management of IBD"],"prefix":"10.2174","volume":"12","author":[{"given":"O.","family":"R. Waters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"C. Lawrance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/74470","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T08:40:30Z","timestamp":1448268030000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1389-4501&volume=12&issue=9&spage=1364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,1]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,8,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/138945011796150343","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8,1]]}}}